Home / NIH / In-Vitro Diagnostic Substance Manufacturing / Notice

Reagents and consumables for Roche immunostainers

Updated

Sources Sought from the National Institutes of Health, for work in Bethesda, Maryland. Due Oct 28, 2026, 9:00 AM (UTC-4), 3 days left.

Be among the first to see new In-Vitro Diagnostic Substance Manufacturing contracts
Only new notices that match, once a day.
Solicitation numberPCA-NCI-04352
AgencyNational Institutes of Health
OfficeNational Institutes of Health Olao
Notice typeSources Sought
Set-asideNone
Trade (NAICS)In-Vitro Diagnostic Substance Manufacturing (325413)
Product or service code6640
Place of performanceBethesda, Maryland
PostedOct 22, 2026
Response deadlineOct 28, 2026, 9:00 AM (UTC-4) (3 days left)
Add the deadline toGoogle Calendar · Apple / Outlook (.ics)
Official notice
Send to a teammate

Bid documents (1)

Paid members download every document from this page, or buy this bid alone.

Description

See attached Sources Sought Notice.

Contracting contact

As published on the official notice. Ask questions in writing and before any questions deadline the notice sets.

Is your business small enough?

For NAICS 325413, a business counts as small if it has no more than 1,250 employees (SBA size standard). This notice is not set aside, but the size decides your small business status on it. SBA table, current as of Oct 15, 2026.

Companies that win this kind of work

Federal contractors paid for in-vitro diagnostic substance manufacturing work, who also hold NIH contracts (last 12 months): possible competitors, or partners to team with.

About the buyer

The National Institutes of Health awarded $5.8 billion in contracts in the last 12 months; its biggest suppliers were Leidos Biomedical Research Inc, M. A. Mortenson Company and Deloitte Consulting LLP. See what NIH is buying now.

In-Vitro Diagnostic Substance Manufacturing contracts right now

There are 17 open government contract opportunities in this trade (NAICS 325413), 6 posted in the last 7 days; 29% are set aside for small businesses. The agencies buying the most are Department of Veterans Affairs, Defense Health Agency (DHA) and National Institutes of Health. Most of the work with a stated place is in Maryland, Washington and Texas. A notice in this trade gives a median of 14 days from posting to deadline; this one gives 6 days.

All open in-vitro diagnostic substance manufacturing contracts

Recent awards in this trade

From the award notices agencies publish.

Similar open in-vitro diagnostic substance manufacturing bids

Redacted Justification and Approval for Other Than Full and Open Competition Sequencing System for HIV-1 Genotype Testing
Defense Health Agency (DHA)
Justification · Silver Spring, MD · Posted Oct 1, 2026
BPA - Consumable Supplies for Terumo Trima Accel Blood Collection systems
Defense Health Agency (DHA)
Due Nov 6, 2026, 12:00 PM (UTC-5) · 12 days left
Solicitation · Service-disabled veteran-owned · JBSA Ft Sam Houston, TX · Posted Oct 23, 2026
VISN Cepheid GeneXpert Testing Supplies Base Plus 3 Op Yr RFQ
Department of Veterans Affairs
Due Nov 5, 2026, 10:00 AM (UTC-5) · 11 days left
Solicitation · Various Locations · Posted Oct 22, 2026
NOI - DNA Sequencing of Bone Marrow Failure Syndro
National Institutes of Health
Due Nov 2, 2026, 9:00 AM (UTC-5) · 8 days left
Solicitation · Posted Oct 22, 2026
Cost Per Reportable Result Purchase of Immunohistochemistry Reagents for Laboratory Tests.
Department of Veterans Affairs
Due Nov 13, 2026, 10:00 AM (UTC-8) · 19 days left
Sources Sought · Seattle, WA · Posted Oct 19, 2026
Hemochron Signature Elite Reagents and Supplies
Department of Veterans Affairs
Due Nov 2, 2026, 12:00 PM (UTC-8) · 8 days left
Sources Sought · Tucson · Posted Oct 18, 2026